Abstract:Abstract BACKGROUND AND AIMS In Moscow, the nephrological service is organized as follows: (1) specialize centres of haemodialysis in which patients with COVID-19 are treated and (2) ordinary departments of haemodialysis, in which there are no patients with coronavirus infection, but patients with COVID-19 are identified in them and these patients are sent for treatment to specialize departments. This study was aimed at examining the level of anxiety and depression in patients on haemodialysis in comparison with a group of medical staff (doctors and nurses) working in the ordinary department of haemodialysis during the COVID-19 pandemic. Also, we were compared both groups with the level of anxiety and depression in the general population of healthy people who lived in the era of the COVID-19 pandemic, based on the results of meta-analysis of 2189 current studies of depressive disorders during the pandemic [1]. METHOD We used the Hospital Anxiety and Depression Scale (HADS) to evaluate the level of anxiety and depression. Before the study, informed consent was taken from all responders to participate in the study, as well as permission to publish the results. In this study, we included 40 stable patients receiving haemodialysis (15 women and 25 men). The average age was 58.6 years (45–84 years). Time spent on haemodialysis: up to 1 year: 9 patients; up to 5 years: 16 patients; and >5 years: 15 patients. Average 4.9 years (1–20 years). The main causes leading to the end stage of renal failure were: polycystic disease (24%), type 2 diabetes mellitus (20%), hypertension (16%), glomerulonephritis (23%) and others (17%). The group of medical staff consisted of 43 people (16 doctors and 27 nurses). The ratio of men and women is 1: 3 and 1: 5.7, respectively. The average age of doctors is 50.3 ± 15.6 years; nurses 34.1 ± 8.2 years. For comparison, we used materials from the meta-analysis [1], where the prevalence of depression was 15.97% and anxiety was 15.15% as the consequence of the COVID-19 pandemic for the mentally healthy population. RESULTS In the group of patients, anxiety and depression were detected in 16 patients (40%), in 4 patients (10%) ––clinically significant. By the time spent on haemodialysis: up to 1 year: 4 patients (without clinically significant manifestations); up to 5 years: 7 patients (3 with clinically significant manifestations); and >5 years: 6 patients (1 with clinically significant manifestations). In the group of medical staff, anxiety and depression were detected in 13 people (32.5%), of which clinically significant in 4 people (9.3%). Anxiety and depression were found in 6 doctors (37.5%) (2 men and 4 women) and in 7 nurses (25.9%) (1 man and 6 women). Clinically significant manifestations were noted in 2 doctors and 2 nurses. In the group of patients, anxiety and depression were observed in 1 young patient, in 5 middle-aged patients and in 10 elderly patients (60–74 years old). In the group of medical workers, an increased level of anxiety and depression were observed in 10 young people and in 3 middle-aged people. CONCLUSION Patients on haemodialysis and dialysis centre staff, the levels of anxiety and depression were twice times higher compared with the data of anxiety and depression in healthy populations during the COVID-19 pandemic. Patients on haemodialysis and medical staff had same level of anxiety and depression. The level of anxiety and depression among doctors was significantly higher than in nurse; this difference can be explained by a small sample, as well as a higher level of education among doctors and a tendency to reflect.

Association of uremic toxins and systemic inflammation with depression and anxiety among hemodialysis patients in Montenegro

Depression and anxiety among patients undergoing dialysis and kidney transplantation: a cross-sectional study

The Plasma Neurofilament Light Chain, Brain-Derived Neurotrophic Factor, and Risk of Depression in Chronic Hemodialysis Patients

Factors associated with depression and anxiety in patients with end-stage renal disease receiving maintenance hemodialysis

Level of Depression and Anxiety on Quality of Life Among Patients Undergoing Hemodialysis

Analysis of influencing factors of anxiety and depression in maintenance hemodialysis patients and its correlation with BDNF, NT-3 and 5-HT levels

Assessment of IL-8, RANTES, MIG, MCP-1, IP-10, and IL-12p70 and Their Association with Anxiety and Quality of Life in Patients with Chronic Kidney Disease or After Kidney Transplantation

Urea Level and Depression in Patients with Chronic Kidney Disease

MO916: Anxiety and Depression Among Dialysis Centre Staff and Haemodialysis Patients During the COVID-19 Pandemic

Vitamin D status in chronic dialysis patients with depression: a prospective study

Survey of Depression by Beck Depression Inventory in Uremic Patients Undergoing Hemodialysis and Hemodiafiltration

Association of Ego Defense Mechanisms with Electrolyte and Inflammation Marker Levels, Interdialytic Weight Gain, Depression, Alexithymia, and Sleep Disorders in Patients Undergoing Chronic Hemodialysis

Depression and death anxiety among patients undergoing hemodialysis during the COVID-19 pandemic in Palestine: a cross sectional study

Prevalence and determinant factors of depression and anxiety in people with chronic kidney disease: a Moroccan cross-sectional study

Correlates of Symptoms of Depression in Maintenance Hemodialysis Patients

Assessment of Depression and Anxiety in Patients with Chronic Kidney Disease and after Kidney Transplantation-A Comparative Analysis

Depression and Anxiety in Patients with Chronic Renal Failure: The Effect of Sociodemographic Characteristics

Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk

Prevalence of depression and anxiety and their predictors among patients undergoing maintenance hemodialysis in Northern China: a cross-sectional study

Depression among end-stage renal disease patients undergoing hemodialysis: a cross-sectional study from Palestine

Psychiatric comorbidity and quality of life in patients undergoing hemodialysis